Innoviva (INVA) Operating Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 376.02% |
| Dec 31, 2025 | -139.98% |
| Sep 30, 2025 | -29.07% |
| Jun 30, 2025 | 17.68% |
| Mar 31, 2025 | 493.09% |
| Dec 31, 2024 | -124.37% |
| Sep 30, 2024 | -20.94% |
| Jun 30, 2024 | 634.67% |
| Mar 31, 2024 | -55.49% |
| Dec 31, 2023 | -107.65% |
| Sep 30, 2023 | 992.64% |
| Jun 30, 2023 | 15.13% |
| Mar 31, 2023 | -9.86% |
| Dec 31, 2022 | -206,660.00% |
| Sep 30, 2022 | 100.05% |
| Jun 30, 2022 | -5.07% |
| Mar 31, 2022 | -45.09% |
| Dec 31, 2021 | -106.40% |
| Sep 30, 2021 | -2.06% |
| Jun 30, 2021 | 1,876.26% |
| Mar 31, 2021 | 15.78% |
| Dec 31, 2020 | -107.64% |
| Sep 30, 2020 | 11.40% |
| Jun 30, 2020 | -0.43% |
| Mar 31, 2020 | 3.36% |
| Dec 31, 2019 | 21.13% |
| Sep 30, 2019 | 1.73% |
| Jun 30, 2019 | 14.55% |
| Mar 31, 2019 | -32.44% |
| Dec 31, 2018 | 33.92% |
| Sep 30, 2018 | -8.00% |
| Jun 30, 2018 | 54.01% |
| Mar 31, 2018 | -38.72% |
| Dec 31, 2017 | 65.93% |
| Sep 30, 2017 | -16.32% |
| Jun 30, 2017 | 63.00% |
| Mar 31, 2017 | -22.09% |
| Dec 31, 2016 | 34.90% |
| Sep 30, 2016 | 7.89% |
| Jun 30, 2016 | 47.60% |
| Mar 31, 2016 | 1.38% |
| Dec 31, 2015 | 105.04% |
| Sep 30, 2015 | 65.11% |
| Jun 30, 2015 | 585.64% |
| Mar 31, 2015 | 473.08% |
| Dec 31, 2014 | 101.36% |
| Sep 30, 2014 | 2.57% |
| Jun 30, 2014 | 33.48% |
| Mar 31, 2014 | -98.50% |
| Dec 31, 2013 | 3.76% |
| Sep 30, 2013 | -11.73% |
| Jun 30, 2013 | 79.34% |
| Mar 31, 2013 | 20.75% |
| Dec 31, 2012 | -26.32% |
| Sep 30, 2012 | 6.61% |
| Jun 30, 2012 | -141.50% |
| Mar 31, 2012 | 341.86% |
| Dec 31, 2011 | -21.82% |
| Sep 30, 2011 | -23.44% |
| Jun 30, 2011 | -11.06% |
| Mar 31, 2011 | -18.79% |
| Dec 31, 2010 | 9.63% |
| Sep 30, 2010 | -2.13% |